Busy with 3 program launches this year, Biogen trims pipeline
Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump
Novartis, helped by cost cuts, raises full-year outlook
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO
*please scroll down for all the latest news*
